医学
乳腺癌
肿瘤科
内科学
化疗
病态的
新辅助治疗
完全响应
癌症
作者
Dandan Guan,Qingyang Shi,Yajuan Zheng,Chaopeng Zheng,Xuli Meng
标识
DOI:10.1016/j.clbc.2024.04.006
摘要
Data on the pathological responses and survival outcomes after neoadjuvant chemotherapy (NACT) in human epidermal growth factor receptor-2 (HER2)-low breast cancer (BC) are lacking. This study aims to investigate this topic in the real world.
科研通智能强力驱动
Strongly Powered by AbleSci AI